New vaccine study aims to shield older kids from Hand-Foot-Mouth disease
NCT ID NCT07178522
First seen Nov 01, 2025 · Last updated May 04, 2026 · Updated 27 times
Summary
This study tests an inactivated EV71 vaccine (Envacgen®) in healthy children aged 6 to 10 years, comparing their immune response and safety to younger children aged 2 to 6 years. The goal is to see if the vaccine works as well in older kids to protect against enterovirus 71, which can cause hand-foot-mouth disease. About 378 children will participate, and researchers will measure antibody levels and any side effects after vaccination.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ENTEROVIRUS 71 INACTIVATED VACCINE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Chang Gung Medical Hospital Linkou
Taoyuan, Taiwan
-
National Taiwan University Hospital
Taipei, Taiwan
-
National Taiwan University Hospital Hsin-Chu Branch
Hsinchu, Taiwan
Conditions
Explore the condition pages connected to this study.